1. Inflammatory crosstalk impairs phagocytic receptors and aggravates atherosclerosis in clonal hematopoiesis in mice
- Author
-
Liu, Wenli, Hardaway, Brian D., Kim, Eunyoung, Pauli, Jessica, Wettich, Justus Leonard, Yalcinkaya, Mustafa, Hsu, Cheng- Chieh, Xiao, Tong, Reilly, Muredach P., Tabas, Ira, Maegdefessel, Lars, Schlepckow, Kai, Haass, Christian, Wang, Nan, and Tall, Alan R.
- Subjects
Macrophages -- Analysis -- Health aspects ,Cell receptors -- Analysis -- Health aspects ,Atherosclerosis -- Risk factors -- Models -- Development and progression ,Health care industry - Abstract
Clonal hematopoiesis (CH) increases inflammasome-linked atherosclerosis, but the mechanisms by which CH mutant cells transmit inflammatory signals to nonmutant cells are largely unknown. To address this question, we transplanted 1.5% [Jak2.sup.V617F] ([Jak2.sup.VF]) bone marrow (BM) cells with 98.5% WT BM cells into hyperlipidemic [Ldlr.sup.-/-] mice. Low-allele-burden (LAB) mice showed accelerated atherosclerosis with increased features of plaque instability, decreased levels of the macrophage phagocytic receptors c-Mer tyrosine kinase (MERTK) and triggering receptor expressed on myeloid cells 2 (TREM2), and increased neutrophil extracellular traps (NETs). These changes were reversed when Jak2VF BM was transplanted with [Il1r1.sup.-/-]BM. LAB mice with noncleavable MERTK in WT BM showed improvements in necrotic core and fibrous cap formation and reduced NETs. An agonistic TREM2 antibody (4D9) markedly increased fibrous caps in both control and LAB mice, eliminating the difference between the groups. Mechanistically, 4D9 increased [TREM2.sup.+][PDGFB.sup.+] macrophages and PDGF receptor-[alpha]* fibroblast-like cells in the cap region. TREM2 and PDGFB mRNA levels were positively correlated in human carotid plaques and coexpressed in macrophages. In summary, low frequencies of Jak2VF mutations promoted atherosclerosis via IL-1 signaling from [Jak2.sup.VF] to WT macrophages and neutrophils, promoting cleavage of phagocytic receptors and features of plaque instability. Therapeutic approaches that stabilize MERTK or TREM2 could promote plaque stabilization, especially in CH- and inflammasome-driven atherosclerosis., Introduction Although LDL-lowering treatments have been proven effective, atherosclerotic cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the United States, accounting for 28% of all deaths [...]
- Published
- 2025
- Full Text
- View/download PDF